Literature DB >> 15150231

Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae.

Krzysztof Trzciński1, Claudette M Thompson, Marc Lipsitch.   

Abstract

The capsule (cps) locus of Streptococcus pneumoniae is flanked by the pbp2x and pbp1a genes, coding for penicillin-binding proteins, enzymes involved in cell wall synthesis that are targets for beta-lactams. This linkage suggested to us that selection for beta-lactam resistance might coselect for capsular transformants. The recombination event would then involve PBP genes, as well as the cps operon, and would change both the serotype and the resistance profile of the strain. We transformed beta-lactam-susceptible strain TIGR4 by using whole genomic DNA extracted from multidrug-resistant strain GA71, a serotype 19F variant of pneumococcal clone Spain(23F)-1, and selected beta-lactam-resistant transformants. Smooth colonies appearing on selective plates were subcultured, serotyped by the Quellung reaction, and genotyped to confirm the presence of the GA71 pbp2x-cps19-pbp1a locus in the TIGR4 genetic background by restriction fragment length polymorphism analysis of the whole locus and its flanking regions. The results showed that a new serotype, combined with resistance to beta-lactams, could emerge in a susceptible strain via a single transformation event. Quantitative analysis showed that transfer of the cps locus had occurred at an elevated rate in beta-lactam-selected transformants. This suggests that in natural settings selection by host immunity and selection by antibiotics may be interrelated because of "hitchhiking" effects due to linkage of resistance determinants and the capsule locus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150231      PMCID: PMC415782          DOI: 10.1128/JB.186.11.3447-3452.2004

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  41 in total

1.  The Significance of Pneumococcal Types.

Authors:  F Griffith
Journal:  J Hyg (Lond)       Date:  1928-01

2.  Alterations in PBP 1A essential-for high-level penicillin resistance in Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  Number of transformable units per cell in Diplococcus pneumoniae.

Authors:  R D Porter; W R Guild
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

4.  Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.

Authors:  P V Adrian; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

5.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

6.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  V A Barcus; K Ghanekar; M Yeo; T J Coffey; C G Dowson
Journal:  FEMS Microbiol Lett       Date:  1995-03-01       Impact factor: 2.742

7.  Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.

Authors:  R Hakenbeck; N Balmelle; B Weber; C Gardès; W Keck; A de Saizieu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site.

Authors:  R Hakenbeck; H Ellerbrok; T Briese; S Handwerger; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

10.  Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X of Streptococcus pneumoniae.

Authors:  C M Kell; U K Sharma; C G Dowson; C Town; T S Balganesh; B G Spratt
Journal:  FEMS Microbiol Lett       Date:  1993-01-15       Impact factor: 2.742

View more
  24 in total

1.  Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.

Authors:  Moses L Joloba; Benson R Kidenya; David P Kateete; Fred A Katabazi; Julian K Muwanguzi; Benon B Asiimwe; Simon P Alarakol; Jessica L Nakavuma; Saralee Bajaksouzian; Anne Windau; Michael R Jacobs
Journal:  Int J Antimicrob Agents       Date:  2010-05-15       Impact factor: 5.283

2.  Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India.

Authors:  Rosemol Varghese; Ayyanraj Neeravi; Jobin John Jacob; Karthick Vasudevan; Jones Lionel Kumar; Nithya Subramanian; Balaji Veeraraghavan
Journal:  Mol Biol Rep       Date:  2021-04-19       Impact factor: 2.316

3.  Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Authors:  David Tarragó; Lorenzo Aguilar; Raquel García; María-José Gimenez; Juan-José Granizo; Asunción Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

4.  Capsule homology does not increase the frequency of transformation of linked penicillin binding proteins PBP 1a and PBP 2x in Streptococcus pneumoniae.

Authors:  Krzysztof Trzciński; Adam MacNeil; Keith P Klugman; Marc Lipsitch
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.

Authors:  Liset Olarte; Sheldon L Kaplan; William J Barson; José R Romero; Philana Ling Lin; Tina Q Tan; Jill A Hoffman; John S Bradley; Laurence B Givner; Edward O Mason; Kristina G Hultén
Journal:  J Clin Microbiol       Date:  2016-11-09       Impact factor: 5.948

Review 6.  Mechanisms of genome evolution of Streptococcus.

Authors:  Cheryl P Andam; William P Hanage
Journal:  Infect Genet Evol       Date:  2014-11-13       Impact factor: 3.342

7.  Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Authors:  Colette Cywes-Bentley; David Skurnik; Tanweer Zaidi; Damien Roux; Rosane B Deoliveira; Wendy S Garrett; Xi Lu; Jennifer O'Malley; Kathryn Kinzel; Tauqeer Zaidi; Astrid Rey; Christophe Perrin; Raina N Fichorova; Alexander K K Kayatani; Tomas Maira-Litràn; Marina L Gening; Yury E Tsvetkov; Nikolay E Nifantiev; Lauren O Bakaletz; Stephen I Pelton; Douglas T Golenbock; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

8.  Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance.

Authors:  Robert DeMars; Jason Weinfurter
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490

Review 9.  Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.

Authors:  Lindsay Kim; Lesley McGee; Sara Tomczyk; Bernard Beall
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

10.  Multiplex gene transfer by genetic transformation between isolated S. pneumoniae cells confined in microfluidic droplets.

Authors:  Trinh Lam; Mark Maienschein-Cline; David T Eddington; Donald A Morrison
Journal:  Integr Biol (Camb)       Date:  2019-12-31       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.